In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate

PURPOSE: Dengue virus infection is now a global problem. Currently, there is no licensed vaccine or proven antiviral treatment against this virus. All four serotypes (1-4) of dengue virus can infect human. An effective dengue vaccine should be tetravalent to induce protective immune responses agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Fahimi, Hossein, Sadeghizadeh, Majid, Mohammadipour, Mahshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742598/
https://www.ncbi.nlm.nih.gov/pubmed/26866023
http://dx.doi.org/10.7774/cevr.2016.5.1.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742598/
https://www.ncbi.nlm.nih.gov/pubmed/26866023
http://dx.doi.org/10.7774/cevr.2016.5.1.41

Ejemplares similares